Cargando…

COPD & COVID-19

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Halpin, David M.G., Vogelmeier, Claus F., Agusti, Alvar A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier España, S.L.U. on behalf of SEPAR. 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816617/ https://www.ncbi.nlm.nih.gov/pubmed/33551276 http://dx.doi.org/10.1016/j.arbres.2021.01.001

Ejemplares similares

COPD & COVID-19
por: Halpin, David M.G., et al.
Publicado: (2021)

Lung Health for All: Chronic Obstructive Lung Disease and World Lung Day 2022
por: Halpin, David M. G., et al.
Publicado: (2022)

Highlights and hot topics in the management of COPD: where are we heading?
por: Agustí, Alvar, et al.
Publicado: (2016)

From GOLD 0 to Pre-COPD
por: Han, MeiLan K., et al.
Publicado: (2021)

Diagnosing COPD
por: Halpin, David MG
Publicado: (2006)

Perception of symptoms and quality of life – comparison of patients’ and physicians’ views in the COPD MIRROR study
por: Celli, Bartolome, et al.
Publicado: (2017)

GOLD COPD DOCUMENT 2023: a brief update for practicing cardiologists
por: Agusti, Alvar, et al.
Publicado: (2023)

Gold 2023: Highlights for primary care
por: Agustí, Alvar, et al.
Publicado: (2023)

New Perspectives on Chronic Obstructive Pulmonary Disease
por: Celli, Bartolome R, et al.
Publicado: (2022)

Natural history of COPD: gaps and opportunities
por: Agustí, Alvar, et al.
Publicado: (2017)

Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective
por: Halpin, David M.G., et al.
Publicado: (2020)

COPD: time to improve its taxonomy?
por: Celli, Bartolomé R., et al.
Publicado: (2018)

Exacerbations of COPD
por: Viniol, Christian, et al.
Publicado: (2018)

Systemic steroids in COPD-the beauty and the beast
por: Vogelmeier, Claus F
Publicado: (2014)

ABCD of the phosphodiesterase family: interaction and differential activity in COPD
por: Halpin, David MG
Publicado: (2008)

Reply to Thomson, to Neder et al., and to Wouters
por: Han, MeiLan K., et al.
Publicado: (2021)

GOLD 2023 Executive Summary: responses from the GOLD Scientific Committee
por: Agustí, Alvar, et al.
Publicado: (2023)

When Harry Met Sally, or When Machine Learning Met Chronic Obstructive Pulmonary Disease
por: Agusti, Alvar, et al.
Publicado: (2020)

Efficacy of indacaterol/glycopyrronium versus salmeterol/fluticasone in current and ex-smokers: a pooled analysis of IGNITE trials
por: Halpin, David M.G., et al.
Publicado: (2021)

When is dual bronchodilation indicated in COPD?
por: Thomas, Mike, et al.
Publicado: (2017)

A review of national guidelines for management of COPD in Europe
por: Miravitlles, Marc, et al.
Publicado: (2016)

COVID-19 and COPD
por: Leung, Janice M., et al.
Publicado: (2020)

Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease
por: Halpin, David M. G., et al.
Publicado: (2021)

Tiotropium and Salmeterol in COPD Patients at Risk of Exacerbations: A Post Hoc Analysis from POET-COPD(®)
por: Vogelmeier, Claus F., et al.
Publicado: (2015)

Haemophilus influenzae induces steroid-resistant inflammatory responses in COPD
por: Cosío, Borja G., et al.
Publicado: (2015)

Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?
por: Halpin, David M G, et al.
Publicado: (2020)

A Response to: Letter to the Editor Regarding “Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-analysis”
por: Ismaila, Afisi S., et al.
Publicado: (2023)

Impact and prevention of severe exacerbations of COPD: a review of the evidence
por: Halpin, David MG, et al.
Publicado: (2017)

Circulating eosinophil levels do not predict severe exacerbations in COPD: a retrospective study
por: Adir, Yochai, et al.
Publicado: (2018)

Exacerbation frequency and course of COPD
por: Halpin, David MG, et al.
Publicado: (2012)

Wir brauchen noch mehr infektiologische Expertise in der Klinik
por: Vogelmeier, Claus Franz
Publicado: (2021)

COVID-19 diagnostic tests: Importance of the clinical context()
por: Vila Muntadas, Marc, et al.
Publicado: (2021)

An investigation of the resolution of inflammation (catabasis) in COPD
por: Noguera, Aina, et al.
Publicado: (2012)

Pruebas diagnósticas COVID-19: importancia del contexto clínico
por: Vila Muntadas, Marc, et al.
Publicado: (2021)

Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations
por: Glaab, Thomas, et al.
Publicado: (2010)

Real-life burden of hospitalisations due to COPD exacerbations in Spain
por: Izquierdo, José Luis, et al.
Publicado: (2022)

Early treatment with inhaled budesonide to prevent clinical deterioration in patients with COVID-19
por: Agusti, Alvar, et al.
Publicado: (2021)

Tiotropium HandiHaler(®) and Respimat(®) in COPD: a pooled safety analysis
por: Halpin, David MG, et al.
Publicado: (2015)

Impact of the COVID-19 pandemic on the behaviour and health status of patients with COPD: results from the German COPD cohort COSYCONET
por: Kahnert, Kathrin, et al.
Publicado: (2021)

Covid-19 and COPD: A Personal Reflection
por: Russell, Richard
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sm7dt634ga19lams6eshiopbmh